Chongqing Pharscin Pharmaceutical (002907)

Chongqing Pharscin Pharmaceutical (002907)

$ 10

Trading Risk Analysis

English Version

Date : 1 Feb 2021


Chongqing Pharscin Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of Chinese patent drugs and chemical drugs. The Company’s products are categorized into the pharmaceuticals of digestive system, nervous system, otorhinolaryngology, cardiovascular and cerebrovascular systems and immune systems. The Company’s products include Weidimei (aluminum carbonate tablets), Ganju Bingmei Tablets, Duliang Soft Capsules, Changsong (Macrogol 4000 Powder), Tongxiening Particles, Bawei Qilong Particles, Liuwei Anshen Capsules, Sodium Ferulate for Injection, Omeprazole Sodium for Injection and Gabexate Mesilate for Injection. The Company mainly distributes its products in domestic market.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner